Stay Up to Date
Breaking News,
Updates, & More
Click Here to
Subscribe

Meg Barbor, MPH

Authored Items
Targeted Intervention Reduces Opioid Use by Nearly 50% After Urologic Oncology Surgery
Meg Barbor, MPH
TOP - February 2019, Vol 12, No 1 in Symptom Management
The Pharmacist’s Role in Improving Quality in Oncology
Meg Barbor, MPH
TOP - November 2018, Vol 11, No 3 in HOPA 2018 Highlights
CAR T-Cell Therapy: Can We Afford the Cure?
Meg Barbor, MPH
TOP - November 2018, Vol 11, No 3 in HOPA 2018 Highlights
Harnessing the Power of Business Intelligence to Influence Oncology Practice
Meg Barbor, MPH
TOP - November 2018, Vol 11, No 3 in HOPA 2018 Highlights
Cannabis for Symptom Management in Cancer: Do You Know What Your Patients Are Using?
Meg Barbor, MPH
TOP - November 2018, Vol 11, No 3 in Symptom Management
Know Your Target: Precision Medicine 101
Meg Barbor, MPH
TON - September 2018, Vol 11, No 4 in ONS 2018
The Samfund Provides Financial Support for Young Adult Cancer Survivors
Meg Barbor, MPH
TON - September 2018, Vol 11, No 4 in Survivorship
Adherence to Exercise and Nutrition Guidelines Can Prolong Life in Cancer Survivors
Meg Barbor, MPH
TON - September 2018, Vol 11, No 4 in Survivorship
Sexual Dysfunction After Cancer: Why Aren’t We Talking About It?
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 in ONS 2018, Conference Correspondent
The Importance of Compassion: Perspective From a Lifelong Patient
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 in ONS 2018, Conference Correspondent
Using a Team Approach to Tackle Opioid Abuse in Patients with Cancer
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 in ONS 2018, Conference Correspondent
Improving Education for Nurse Practitioners Delivering Survivorship Care
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 in Survivorship
Maintaining Work and Productivity a Priority for Cancer Survivors
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 in Survivorship
Encourage Minority Patients with Ovarian Cancer to Participate in Clinical Trials
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 in Gynecologic Cancers
Updates on Immunotherapy in Advanced Melanoma
Meg Barbor, MPH
TOP - May 2018, Vol 11, No 1 in Melanoma, HOPA 2018 Highlights
Understanding Immunotherapy Late Adverse Effects in Cancer Survivors
Meg Barbor, MPH
TOP - May 2018, Vol 11, No 1 in Adverse Effects
Targeting FMS-Like Tyrosine Kinase 3 in the Management of Patients with FLT3-Positive Acute Myeloid Leukemia
Meg Barbor, MPH
TOP - May 2018, Vol 11, No 1 in HOPA 2018 Highlights, Leukemia
The Strengths and Pitfalls of PD-L1 as a Biomarker for Immunotherapy
Meg Barbor, MPH
TOP - May 2018, Vol 11, No 1 in HOPA 2018 Highlights
“Superhero” Navigators Convene at the 8th Annual Navigation & Survivorship Conference
Meg Barbor, MPH
TON - March 2018, Vol 11, No 1 in AONN+ News, Conference Correspondent
The Challenges of Oral Cancer Drugs Use and Side-Effects Management
Meg Barbor, MPH
TON - March 2018, Vol 11, No 1 in ESMO, Drug Updates, Side-Effects Management
Silent Patients Find Their Voices Through an Advocate’s Journey
Meg Barbor, MPH
TON - March 2018, Vol 11, No 1 in Patient Advocacy, Conference Correspondent, ESMO
Measuring Financial Well-Being in Cancer Survivorship
Meg Barbor, MPH
TON - March 2018, Vol 11, No 1 in Conference Correspondent, Survivorship
Supportive Care Updates from ASCO 2017 Highlighted at New Orleans Summer Cancer Meeting
Meg Barbor, MPH
TON - November 2017, Vol 10, No 6 in Supportive Care
Practice-Changing Results with Abiraterone plus Prednisone in Metastatic Hormone-Naïve Prostate Cancer
Meg Barbor, MPH
TON - November 2017, Vol 10, No 6 in Prostate Cancer
The Role of Integrative and Alternative Medicine in Cancer Care
Meg Barbor, MPH
TON - November 2017, Vol 10, No 6 in Alternative Medicine
Addressing Usability Concerns in Oncology Electronic Health Records
Meg Barbor, MPH
TON - September 2017, Vol 10, No 5 in Best Practices
New Drug Therapies for Relapsed or Refractory Multiple Myeloma
Meg Barbor, MPH
TOP - August 2017, Vol 10, No 3 in Multiple Myeloma
Evidence Supports the Use of Aspirin for Precision Chemoprevention of Colorectal Cancer
Meg Barbor, MPH
TOP - August 2017, Vol 10, No 3 in Colorectal Cancer
AONN+ Regional Meeting Addresses the Rapidly Evolving Role of the Navigator
Meg Barbor, MPH
TON - July 2017, Vol 10, No 4 in Conference Correspondent
Helping Adolescents and Young Adults Confront Mortality
Meg Barbor, MPH
TON - May 2017, Vol 10, No 3 in Supportive Care
Multidisciplinary Oral Chemotherapy Clinic Leads to Positive Changes in a Community Hospital
Meg Barbor, MPH
TON - May 2017, Vol 10, No 3 in Best Practices
Effectively Communicating with Older Adults with Cancer
Meg Barbor, MPH
TON - May 2017, Vol 10, No 3 in Best Practices
Complexity Associated with Near Miss or Safety Incidents in Patients Treated with Radiotherapy
Meg Barbor, MPH
TON - May 2017, Vol 10, No 3 in Best Practices
The Emerging Conversation About Physician-Assisted Death
Meg Barbor, MPH
TON - May 2017, Vol 10, No 3 in Supportive Care
Managing Immune-Related Toxicities in Patients with Lung Cancer
Meg Barbor, MPH
TOP - May 2017, Vol 10, No 2 in Lung Cancer
Evidence Supports the Use of Aspirin for Precision Chemoprevention of Colorectal Cancer
Meg Barbor, MPH
TON - March 2017, Vol 10, No 2 in Colorectal Cancer
Managing Immune-Related Toxicities in Patients with Lung Cancer
Meg Barbor, MPH
TON - March 2017, Vol 10, No 2 in Lung Cancer
The Effect of a Home-Based Exercise Intervention on Metabolic Syndrome and Breast Cancer Risk in African-American Women
Meg Barbor, MPH
TON - March 2017, Vol 10, No 2 in Breast Cancer
Breast Density, Elevated Breast Cancer Risk Highest in Hispanic Women
Meg Barbor, MPH
TON - March 2017, Vol 10, No 2 in Breast Cancer
Increased Risk for Breast Cancer in Shift Workers Possibly Associated with Epigenetic Changes in Circadian Pathway
Meg Barbor, MPH
TON - March 2017, Vol 10, No 2 in Breast Cancer
Recognizing Compassion Fatigue: The First Step to Building Resilience
Meg Barbor, MPH
TON - March 2017, Vol 10, No 2 in Best Practices
E-Cigarettes: The New Threat to Public Health
Meg Barbor, MPH
TON - March 2017, Vol 10, No 2 in Lung Cancer
Transitioning from Inpatient to Outpatient Chemotherapy Saves Money, Increases Patient Satisfaction
Meg Barbor, MPH
TOP - February 2017, Vol 10, No 1 in Conference Correspondent
Delirium Symptoms More Severe in Patients Treated with Antipsychotics
Meg Barbor, MPH
TOP - February 2017, Vol 10, No 1 in Palliative Care
Immunotherapy for the Treatment of Patients with Malignant Pleural Mesothelioma
Meg Barbor, MPH
TOP - February 2017, Vol 10, No 1 in Immunotherapy
Is Value-Based Pricing the Solution to Unaffordable Anticancer Drugs?
Meg Barbor, MPH
TOP - February 2017, Vol 10, No 1 in Conference Correspondent
Improved Patient Adherence in a Pharmacy-Led Oral Chemotherapy Program
Meg Barbor, MPH
TOP - February 2017, Vol 10, No 1 in Conference Correspondent
Novel Cytotoxic Drugs Still Play an Important Role in the Treatment of Lung Cancer
Meg Barbor, MPH
TOP - February 2017, Vol 10, No 1 in Lung Cancer
AONN+ Annual Conference Deemed a Success
Meg Barbor, MPH
TON - January 2017, Vol 10, No 1 in Conference Correspondent, AONN+ News
Delirium Symptoms More Severe in Patients Treated with Antipsychotics
Meg Barbor, MPH
TON - January 2017, Vol 10, No 1 in Palliative Care
Probiotics Hold Promise for Preventing Radiation Enteropathy
Meg Barbor, MPH
TON - January 2017, Vol 10, No 1 in Supportive Care
Providing Spiritual Care to Patients with Cancer Across the Continuum
Meg Barbor, MPH
TON - January 2017, Vol 10, No 1 in Best Practices
HOPA Conference Highlights
Meg Barbor, MPH
JHOP - December 2016 Vol 6, No 4 in Conference Correspondent
Challenges in ALK-Positive NSCLC Management
Meg Barbor, MPH
Online First in Conference Correspondent
Lowering the High Cost of USP 800 Compliance
Meg Barbor, MPH
Online First
Oncology Nurses Survey Reveals Inconsistent Adherence to Antiemetic Prophylaxis Guidelines
Meg Barbor, MPH
TON - November 2016, Vol 9, No 6 in Best Practices
Gaps Found in Nutritional Care for Patients with Head and Neck Cancer
Meg Barbor, MPH
TON - November 2016, Vol 9, No 6 in Head and Neck Cancer
Medical Nutrition Therapy Shows Promise in Patients with Lung Cancer
Meg Barbor, MPH
TON - November 2016, Vol 9, No 6 in Lung Cancer
SGX942 Decreases Duration of Severe Oral Mucositis in Patients with Head and Neck Cancer
Meg Barbor, MPH
TON - November 2016, Vol 9, No 6 in Supportive Care
Managing Delirium in Patients with Cancer
Meg Barbor, MPH
TON - November 2016, Vol 9, No 6 in Supportive Care
Scalp Cooling Now Frequently Used for Preventing Chemotherapy-Induced Alopecia
Meg Barbor, MPH
TON - November 2016, Vol 9, No 6 in Supportive Care
Treating Nausea as a Symptom Cluster
Meg Barbor, MPH
TON - November 2016, Vol 9, No 6 in Supportive Care
Posters of Interest from the 2016 MASCC/ISOO Annual Meeting
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4 in Conference Correspondent
Probiotics Hold Promise for Preventing Radiation Enteropathy
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4 in Supportive Care
SGX942 Decreases Duration of Severe Oral Mucositis in Patients with Head and Neck Cancer
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4 in Supportive Care
Managing Delirium in Patients with Cancer
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4 in Supportive Care
Treating Nausea as a Symptom Cluster
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4 in Supportive Care
Challenges in ALK-Positive Non–Small-Cell Lung Cancer Management
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4 in Conference Correspondent
Certain Measures Can Lower the High Cost of USP 800 Compliance
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4 in Conference Correspondent
USP 800: Navigating the New Requirements for Handling Hazardous Drugs
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4 in Conference Correspondent
“Magic Mouthwash” for mTOR Inhibitor–Associated Stomatitis?
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4 in Supportive Care
The New World of Biosimilars
Meg Barbor, MPH
TOP - August 2016, Vol 9, No 3 in Oncology Update
An Update on CancerLinQ—ASCO’s Big Data Cancer Database
Meg Barbor, MPH
TOP - August 2016, Vol 9, No 3 in Technology Update
Molecular Profiling Is Vital in Patients with Metastatic Cancer
Meg Barbor, MPH
TOP - August 2016, Vol 9, No 3 in Oncology Update
How to Assess Quality in the Age of Precision Medicine
Meg Barbor, MPH
TON July 2016 Vol 9 No 4 in Conference Correspondent
Molecular Profiling Is Vital in Patients with Metastatic Cancer
Meg Barbor, MPH
TON July 2016 Vol 9 No 4 in Conference Correspondent
The Benefits of Triage and the COME HOME Model
Meg Barbor, MPH
TON July 2016 Vol 9 No 4 in Conference Correspondent
Significant Roadblocks to Oncology Appointments at NCI Cancer Centers
Meg Barbor, MPH
TON July 2016 Vol 9 No 4 in Conference Correspondent
Immunotherapy: Separating Facts from Fiction
Meg Barbor, MPH
TON July 2016 Vol 9 No 4 in Conference Correspondent, Immunotherapy
An Update on CancerLinQ—ASCO’s Big Data Cancer Database
Meg Barbor, MPH
TON July 2016 Vol 9 No 4 in Technology Update
Functional Impairments of Head and Neck Lymphedema
Meg Barbor, MPH
TON July 2016 Vol 9 No 4 in Supportive Care
Low-Level Laser Therapy Reduces Pain in Patients with Head and Neck Cancer
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2 in Head and Neck Cancer
Severe Oral Mucositis Less Frequent, Briefer, Less Severe with Use of GC4419
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2 in Head and Neck Cancer
Prophylactic Gabapentin Linked to Weight Loss, Narcotic Dependency
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2 in Conference Correspondent, Head and Neck Cancer
Lower Readmission Rates Associated with Pharmacist-Assisted Transitional Care Program
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2 in Conference Correspondent
ASHP Foundation Forecast Provides Actionable Recommendations for Pharmacy Leaders
Meg Barbor, MPH
TOP - February 2016, Vol 9, No 1 in Leadership
Aprepitant Reduces Cough Severity in Patients with Lung Cancer
Meg Barbor, MPH
TOP - February 2016, Vol 9, No 1 in Lung Cancer
Personalized Medicine as a Vital Aspect of Palliative Care
Meg Barbor, MPH
TON January 2016 Vol 9 No 1 in Palliative Care
Earlier Goals-of-Care Conversations Improve Patient Outcomes
Meg Barbor, MPH
TON January 2016 Vol 9 No 1 in Palliative Care
Keeping Loved Ones in the Loop
Meg Barbor, MPH
TON January 2016 Vol 9 No 1 in The Patient's Voice
Aspergillus and the Azoles in 2015
Meg Barbor, MPH
TOP November 2015 Vol 8 No 4 in Supportive Care
Intravenous Iron Better Tolerated Than Oral Iron for Chemotherapy-Induced Anemia
Meg Barbor, MPH
TOP November 2015 Vol 8 No 4 in Conference Correspondent
Successful Navigation of Oncology Pharmacy Services Affiliation Agreements
Meg Barbor, MPH
TOP November 2015 Vol 8 No 4 in Conference Correspondent
The Perceptual Gap in the Impact of Chemotherapy- and Radiotherapy-Induced Nausea and Vomiting
Meg Barbor, MPH
TOP November 2015 Vol 8 No 4 in Supportive Care
Docetaxel plus Nintedanib Tolerated in Patients with NSCLC
Meg Barbor, MPH
TOP November 2015 Vol 8 No 4 in Conference Correspondent
The Perceptual Gap in the Impact of Chemotherapy- and Radiotherapy-Induced Nausea and Vomiting
Meg Barbor, MPH
TON September 2015 Vol 8 No 5 in Supportive Care
Antiemesis Prophylaxis Remains Inadequate
Meg Barbor, MPH
TON September 2015 Vol 8 No 5 in Supportive Care
Rolapitant Effective for Chemotherapy-Induced Nausea and Vomiting
Meg Barbor, MPH
TOP - August 2015, Vol 8, No 3 in Conference Correspondent
Pharmacy Services: Successful Navigation of Oncology Pharmacy Services Affiliation Agreements
Meg Barbor, MPH
Web Exclusives in Practical Issues for Pharmacists
Developing a Pharmacist-Driven Drug-Monitoring Protocol
Meg Barbor, MPH
TOP - August 2015, Vol 8, No 3 in Conference Correspondent
Late Toxicities in Pediatric Cancer Care
Meg Barbor, MPH
TOP - August 2015, Vol 8, No 3 in Pediatric Cancer
Meeting USP Chapter 800 Head On
Meg Barbor, MPH
TOP - August 2015, Vol 8, No 3 in Conference Correspondent
Osteonecrosis of the Jaw Associated with Medication, Not Extraction
Meg Barbor, MPH
TOP - August 2015, Vol 8, No 3
Late Toxicities in Pediatric Cancer Care
Meg Barbor, MPH
TON July 2015 Vol 8 No 4 in Pediatric Cancer
The Ins and Outs of Disposing of Oral Cancer Drugs
Meg Barbor, MPH
TON July 2015 Vol 8 No 4 in Best Practices
The Ins and Outs of Disposing Oral Cancer Drugs
Meg Barbor, MPH
TOP - May 2015, Vol 8, No 2 in Conference Correspondent
Shift Work, Sleep Deprivation, and Cancer Risk
Meg Barbor, MPH
TOP - May 2015, Vol 8, No 2 in Best Practices
The Pharmacist’s Role in Hospice and Palliative Care
Meg Barbor, MPH
TOP - May 2015, Vol 8, No 2 in Conference Correspondent
Pharmacists Can Play an Active Role in Survivorship Care
Meg Barbor, MPH
TOP - May 2015, Vol 8, No 2 in Survivorship
Effective Lung Cancer Screening
Meg Barbor, MPH
TOP - February 2015, Vol 8, No 1 in Lung Cancer
Shift Work, Sleep Deprivation, and Cancer Risk
Meg Barbor, MPH
TON - January 2015 Vol 8 No 1 in Best Practices
Effective Lung Cancer Screening
Meg Barbor, MPH
TON - January 2015 Vol 8 No 1 in Lung Cancer
The Psychosocial Effects of Chemotherapy-Induced Alopecia
Meg Barbor, MPH
TON - September/October 2014 Vol 7 No 5 in Supportive Care
Vaginal DHEA May Improve Sexual Function in Women With Breast/Gynecologic Cancer
Meg Barbor, MPH
TON - September/October 2014 Vol 7 No 5 in Supportive Care
Vaginal DHEA May Improve Sexual Function in Women With Breast/Gynecologic Cancer
Meg Barbor, MPH
TOP - October 2014, Vol 7, No 4 in Supportive Care
The Psychosocial Effects of Chemotherapy-Induced Alopecia
Meg Barbor, MPH
TOP - October 2014, Vol 7, No 4 in Supportive Care
Positive Patient Outcomes Observed With a Pharmacist- Physician Collaboration in a Palliative Care Outpatient Practice
Meg Barbor, MPH
TOP - August 2014, Vol 7, No 3 in Best Practices
Last modified: May 18, 2016